Home Healthcare IT Global Artificial Heart Market Size, Top Share, Demand, Forecast to 2033

Artificial Heart Market Size, Share & Trends Analysis Report By Product Type (Total Artificial Heart, Ventricular Assist Device (VAD)), By Application (Clinics, Hospitals, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI55467DR
Last Updated : Jan 16, 2025
Author : Debashree Bora
Starting From
USD 2300
Buy Now

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Artificial Heart Market Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Total Artificial Heart
        1. By Value
      3. Ventricular Assist Device (VAD)
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Clinics
        1. By Value
      3. Hospitals
        1. By Value
      4. Others
        1. By Value
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Total Artificial Heart
        1. By Value
      3. Ventricular Assist Device (VAD)
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Clinics
        1. By Value
      3. Hospitals
        1. By Value
      4. Others
        1. By Value
    4. U.S.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Total Artificial Heart
          1. By Value
        3. Ventricular Assist Device (VAD)
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Clinics
          1. By Value
        3. Hospitals
          1. By Value
        4. Others
          1. By Value
    5. Canada
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Total Artificial Heart
        1. By Value
      3. Ventricular Assist Device (VAD)
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Clinics
        1. By Value
      3. Hospitals
        1. By Value
      4. Others
        1. By Value
    4. U.K.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Total Artificial Heart
          1. By Value
        3. Ventricular Assist Device (VAD)
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Clinics
          1. By Value
        3. Hospitals
          1. By Value
        4. Others
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Total Artificial Heart
        1. By Value
      3. Ventricular Assist Device (VAD)
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Clinics
        1. By Value
      3. Hospitals
        1. By Value
      4. Others
        1. By Value
    4. China
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Total Artificial Heart
          1. By Value
        3. Ventricular Assist Device (VAD)
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Clinics
          1. By Value
        3. Hospitals
          1. By Value
        4. Others
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Singapore
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Total Artificial Heart
        1. By Value
      3. Ventricular Assist Device (VAD)
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Clinics
        1. By Value
      3. Hospitals
        1. By Value
      4. Others
        1. By Value
    4. UAE
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Total Artificial Heart
          1. By Value
        3. Ventricular Assist Device (VAD)
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Clinics
          1. By Value
        3. Hospitals
          1. By Value
        4. Others
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Total Artificial Heart
        1. By Value
      3. Ventricular Assist Device (VAD)
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Clinics
        1. By Value
      3. Hospitals
        1. By Value
      4. Others
        1. By Value
    4. Brazil
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Total Artificial Heart
          1. By Value
        3. Ventricular Assist Device (VAD)
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Clinics
          1. By Value
        3. Hospitals
          1. By Value
        4. Others
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Artificial Heart Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. BiVACOR
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. CARMAT
    3. SynCardia Systems
    4. ReinHeart TAH
    5. ABIOMED
    6. Abbott
    7. Cirtec
    8. LivaNova
    9. Jarvik Heart
    10. CryoLife
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Artificial Insemination Market Size & Insights The global artificial insemination market size was valued at USD 2.27 billion in 2024 and is projected to reach from USD 2.46 billion in 2025 to USD 4.66 billion by 2033, exhibit
Buy Now
Global Report
Market Overview The global artificial meat market size was valued at USD 228.4 million in 2023 and is expected to Project at USD 6395.78 Million by 2032 at a compound annual growth rate (CAGR) of 51.67% from 2024 to 2032. Artificial meat also referr
Buy Now
Global Report
Artificial Organs Market Size & Trends The global artificial organs market size was valued at USD 20.6 billion in 2023 and is projected to reach from USD 22.2 billion to USD 40.6 billion by 2032, registering a CAGR of 7.83% during the forec
Buy Now
Global Report
Market OverviewThe global artificial sweetener market size was valued at USD 2.7 billion in 2023 and is projected to reach a value of USD 3.56 billion by 2032, registering a CAGR of 7.25% during the forecast period (2024-2032). The increase in artifi
Buy Now
Global Report
The Total Addressable Market (TAM) for artificial tears size was valued at USD 2.74 billion in 2022. It is projected to reach USD 4.40 billion by 2031, growing at a CAGR of 5.40% during the forecast period (2023-2031). Artificial tears solution
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :